Description: MAGE A4 (230-239) is a peptide sequence derived from the MAGE-A4 protein. This immunogenic epitope has the capability to activate T cells and induce cytotoxic responses against tumor cells expressing MAGE-A4. MAGE A4 (230-239) is utilized in developing next-generation T-cell-based immunotherapies.